Alliancebernstein L.P. Cullinan Oncology, Inc. Transaction History

Alliancebernstein L.P.

$290 Billion
Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 47,630 shares of CGEM stock, worth $325,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,630

Previous 1,723,001 97.24%

Holding current value

$325,789

Previous $13 Million 97.26%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$7.13 - $9.08 $11.9 Million - $15.2 Million	-1,675,371 Reduced 97.24%	47,630 $358,000
Q1 2025 May 15, 2025	SELL	$7.57 - $12.68 $2.18 Million - $3.66 Million	-288,524 Reduced 14.34%	1,723,001 $13 Million
Q4 2024 Feb 12, 2025	BUY	$10.77 - $17.6 $1.69 Million - $2.77 Million	157,115 Added 8.47%	2,011,525 $24.5 Million
Q3 2024 Nov 14, 2024	BUY	$16.03 - $20.86 $2.02 Million - $2.63 Million	125,865 Added 7.28%	1,854,410 $31 Million
Q2 2024 Aug 14, 2024	BUY	$15.63 - $29.35 $26.5 Million - $49.8 Million	1,695,345 Added 5106.46%	1,728,545 $30.1 Million
Q1 2024 May 14, 2024	SELL	$10.17 - $19.02 $103,530 - $193,623	-10,180 Reduced 23.47%	33,200 $565,000
Q4 2023 Feb 14, 2024	SELL	$7.89 - $10.23 $2,840 - $3,682	-360 Reduced 0.82%	43,380 $442,000
Q2 2023 Aug 15, 2023	BUY	$8.8 - $13.4 $97,152 - $147,936	11,040 Added 33.76%	43,740 $470,000
Q1 2023 May 15, 2023	BUY	$10.2 - $11.91 $45,900 - $53,595	4,500 Added 15.96%	32,700 $334,000
Q4 2022 Feb 14, 2023	BUY	$9.72 - $13.62 $14,580 - $20,430	1,500 Added 5.62%	28,200 $297,000
Q3 2022 Nov 15, 2022	BUY	$11.82 - $15.42 $28,368 - $37,008	2,400 Added 9.88%	26,700 $342,000
Q2 2022 Aug 15, 2022	BUY	$7.31 - $13.55 $74,562 - $138,210	10,200 Added 72.34%	24,300 $312,000
Q1 2022 May 13, 2022	SELL	$10.47 - $16.75 $18,846 - $30,150	-1,800 Reduced 11.32%	14,100 $148,000
Q4 2021 Feb 14, 2022	BUY	$15.36 - $25.0 $32,256 - $52,500	2,100 Added 15.22%	15,900 $245,000
Q2 2021 Jul 30, 2021	BUY	$24.96 - $41.25 $344,448 - $569,250	13,800 New	13,800 $355,000

Others Institutions Holding CGEM

# of Institutions

153

Shares Held

66.5M

Call Options Held

10.6K

Put Options Held

917K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $312M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Cullinan Oncology, Inc. Transaction History